Heat Biologics, Inc. (HTBX) jumped 0.9 percent and ended the day at $0.79. The Average Volume of the company is 1.11 Million and P/E (price to earnings) ratio is 0, while Forward P/E ratio is 0.

ROTH Capital Initiated its coverage for Heat Biologics, Inc. (HTBX) in a note sent to investors on 20-Jun-16. The research firm Initiated the stock to Buy. Moreover, Noble Financial issued Initiated rating for the stock on 8-Jan-16. H.C. Wainwright also Initiated the company to Buy on 26-May-15, 2016. Additionally, Aegis Capital Initiated its ratings on the stock to Buy.

The highest price HTBX stock touched in the last 12 month was $3.35 and the lowest price it hit in the same period was $0.40. The stock has a Return on Assets of -125.5 percent, Return on Investment of -149.2 percent and a Return on Equity of -205.5 percent. The company’s market cap is $26.39 Million.

Heat Biologics, Inc. (HTBX) has been given an average price target of $4 from analysts, according to data collected by Finviz.

Now we look at the Moving Averages, the 200-day is -30.35, the 50-day is -9.35 and the 20-day is -3.91. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.

Looking forward, the company is expected to report earnings of $-0.15 per share for the current quarter. Revenue is expected in between 130 Million and 130 Million with an average of 130 Million.

Heat Biologics, Inc. (HTBX) has a mean recommendation of 1, according to data compiled by Zacks Investment Research. The recommendation scale measures the value from 1 to 5, where 1 means ‘’Strong Buy’’ and 5 stands for ’’Sell’’.

Heat Biologics, Inc. (HTBX) performance during the last one year Improved 9.31 percent, while its year to date (YTD) performance showed a Negative trend of -8.49 percent. The stock Fell -36.02 percent over the past six months. The stock’s quarterly performance indicates a Negative momentum of -18.02 percent, whereas its last one month trend is Pessimistic with -9.54 percent. Its weekly performance showed a upward trend of 3.55 percent.

Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at 0 percent, operating profit margin was 0 percent, whereas gross profit margin stands at 0 percent. Beta factor was calculated at 0.83.

Heat Biologics, Inc. (HTBX) has 33.72 Million shares outstanding and 31.18 Million shares were floated in market. The short ratio in the company’s stock is documented at 2.58 and the short float is around of 9.2%. The stock’s average true range of stands at 0.05, while the relative strength index is 43.7.

Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 5.2, current ratio was 5.2, LT Debt/Equity ratio was 0 and Total Debt/Equity ratio was 0.